Specific higher levels of serum uric acid might have a protective effect on bone mineral density within a Chinese population over 60 years old: a cross-sectional study from northeast China

References

• Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2):S3–S11. doi:10.1016/j.ajog.2005.08.04716448873
   PubMed Web of Science ®Google Scholar
• Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(2):4–9. doi:10.1016/j.bone.2005.07.01616139579
   PubMed Web of Science ®Google Scholar
• Karasik D, Cohenzinder M. The genetic pleiotropy of musculoskeletal aging. Front Physiol. 2012;3(3):303. doi:10.3389/fphys.2012.0030322934054
   PubMed Web of Science ®Google Scholar
• Wilson C. Bone: oxidative stress and osteoporosis. Nat Rev Endocrinol. 2014;10(1):3.
   Google Scholar
• Kousteni S. FoxOs: unifying links between oxidative stress and skeletal homeostasis. Curr Osteoporos Rep. 2011;9(2):60–66. doi:10.1007/s11914-011-0054-321404001
   PubMedGoogle Scholar
• Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J MolSci. 2010;11(4):1509–1526. doi:10.1155/2010/354189
   PubMed Web of Science ®Google Scholar
• Mainini G, Rotondi M, Di NK, et al. Oral supplementation with antioxidant agents containing alpha lipoic acid: effects on postmenopausal bone mass. Clin Exp Obstet Gynecol. 2012;39(4):489–493.23444750
   PubMed Web of Science ®Google Scholar
• Mlakar SJ, Osredkar J, Prezelj J, Marc J. The antioxidant enzyme GPX1 gene polymorphisms are associated with low BMD and increased bone turnover markers. Dis Markers. 2010;29(2):71–80. doi:10.1155/2010/35418921045266
   PubMed Web of Science ®Google Scholar
• Keizman D, Ishshalom M, Berliner S, et al. Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci. 2009;285(1):95–99. doi:10.1016/j.jns.2009.06.00219552925
   PubMed Web of Science ®Google Scholar
• Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides. 2008;27(6–7):608–619. doi:10.1080/15257770802138558
   Google Scholar
• Donghui MM. Moderate levels of plasma uric acid could promote fracture healing. Med Hypotheses. 2010;75(6):682. doi:10.1016/j.mehy.2010.07.054
   Web of Science ®Google Scholar
• Nabipour I, Sambrook PN, Blyth FM, et al. Serum uric acid is associated with bone health in older men: a cross‐sectional population‐based study. J Bone Miner Res. 2011;26(5):955–964. doi:10.1002/jbmr.28621541998
   PubMed Web of Science ®Google Scholar
• Ahn SH, Lee SH, Kim BJ, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int. 2013;24(12):2961–2970. doi:10.1007/s00198-013-2377-723644878
   PubMed Web of Science ®Google Scholar
• Makovey J, Macara M, Chen JS, et al. Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone. 2013;52(1):400–406. doi:10.1016/j.bone.2012.10.02523111314
   PubMed Web of Science ®Google Scholar
• Kaushal N, Vohora D, Jalali RK, Jha S. Raised serum uric acid is associated with higher bone mineral density in a cross-sectional study of a healthy Indian population. Ther Clin Risk Manag. 2018;14:75–82. doi:10.2147/TCRM.S14769629379298
   PubMed Web of Science ®Google Scholar
• Ishii S, Miyao M, Mizuno Y, Tanaka-Ishikawa M, Akishita M, Ouchi Y. Association between serum uric acid and lumbar spine bone mineral density in peri- and postmenopausal Japanese women. Osteoporos Int. 2014;25(3):1099–1105. doi:10.1007/s00198-013-2571-724318630
   PubMed Web of Science ®Google Scholar
• Kim BJ, Baek S, Ahn SH, et al. Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporos Int. 2014;25(7):1837–1844. doi:10.1007/s00198-014-2697-224668006
   PubMed Web of Science ®Google Scholar
• Chen L, Peng Y, Fang F, Chen J, Pan L, You L. Correlation of serum uric acid with bone mineral density and fragility fracture in patients with primary osteoporosis: a single-center retrospective study of 253 cases. Int J Clin Exp Med. 2015;8(4):6291–6294.26131242
   PubMed Web of Science ®Google Scholar
• Zhao DD, Jiao PL, Yu JJ, et al. Higher serum uric acid is associated with higher bone mineral density in chinese men with type 2 diabetes mellitus. Int J Endocrinol. 2016,(2016-2-28) 2016;2016(6):2528956. doi:10.1155/2016/252895627022396
   PubMed Web of Science ®Google Scholar
• Dong X, Tian H, He J, Wang C, Qiu R, Chen Y. Elevated serum uric acid is associated with greater bone mineral density and skeletal muscle mass in middle-aged and older adults. PLoS One. 2016;11(5):e0154692. doi:10.1371/journal.pone.015469227144737
   PubMed Web of Science ®Google Scholar
• Xiao J, Chen W, Feng X, et al. Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years. Clin Interv Aging. 2017;12:445–452. doi:10.2147/CIA.S13069028280317
   PubMed Web of Science ®Google Scholar
• Sritara C, Ongphiphadhanakul B, Chailurkit L, Yamwong S, Ratanachaiwong W, Sritara P. Serum uric acid levels in relation to bone-related phenotypes in men and women. J Clin Densitom. 2013;16(3):336–340. doi:10.1016/j.jocd.2012.05.00822727551
   PubMed Web of Science ®Google Scholar
• Muka T, de Jonge EA, Kiefte-de Jong JC, et al. The influence of serum uric acid on bone mineral density, hip geometry and fracture risk: the Rotterdam Study. J Clin Endocrinol Metab. 2015;101(3):jc20152446.
   Web of Science ®Google Scholar
• Veronese N, Bolzetta F, De RM, et al. Serum uric acid and incident osteoporotic fractures in old people: the PRO.V.A study. Bone. 2015;79:183–189. doi:10.1016/j.bone.2015.06.00526079996
   PubMed Web of Science ®Google Scholar
• Zhang D, Bobulescu IA, Maalouf NM, et al. Relationship between serum uric acid and bone mineral density in the general population and in rats with experimental hyperuricemia. J Bone Miner Res. 2015;30(6):992–999. doi:10.1002/jbmr.243025491196
   PubMed Web of Science ®Google Scholar
• Liu R, Han C, Wu D, et al. prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015(15, supplement):1–12.
   Google Scholar
• Qiu L, Cheng XQ, Wu J, et al. Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces. BMC Public Health. 2013;13(1):664. doi:10.1186/1471-2458-13-66423866159
   PubMed Web of Science ®Google Scholar
• Peng C, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16(1):1039. doi:10.1186/s12889-016-3712-727716144
   PubMed Web of Science ®Google Scholar
• He L, Sun Y, Yao W, Pan K. The prevalence rate of osteoporosis in the elderly in China between 2010 and 2016: a meta-analysis of single rate. Chin J Osteoporos. 2016;22(12):1590–1596. (Chinese).
   Google Scholar
• Cornelius C, Koverech G, Crupi R, et al. Osteoporosis and alzheimer pathology: role of cellular stress response and hormetic redox signaling in aging and bone remodeling. Front Pharmacol. 2014;5:120. doi:10.3389/fphar.2014.0012024959146
   PubMed Web of Science ®Google Scholar
• Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol Med. 2009;15(10):468–477. doi:10.1016/j.molmed.2009.08.00419811952
   PubMed Web of Science ®Google Scholar
• Bai XC, Lu D, Liu AL, et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem. 2005;280(17):17497. doi:10.1074/jbc.M40933220015731115
   PubMed Web of Science ®Google Scholar
• Reed DR, Price RA. X-linkage does not account for the absence of father-son similarity in plasma uric acid concentrations. Am J Med Genet. 2000;92(2):142–146.10797440
   PubMed Web of Science ®Google Scholar
• Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E. The sex-specific association of serum OPG and RANKL with bone mineral density in older adults: the Rancho Bernardo Study. Eur J Endocrinol. 2007;156(5):555. doi:10.1530/EJE-06-075317468191
   PubMed Web of Science ®Google Scholar
• Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J, Higashino K. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Adv Exp Med Biol. 1998;431:336.
   Web of Science ®Google Scholar
• Jarrar K, Amasheh RA, Graef V, Weidner W. Relationship between 1,25-dihydroxyvitamin-D, calcium and uric acid in urinary stone formers. Urol Int. 1996;56(1):16–20. doi:10.1159/0002828018903548
   PubMed Web of Science ®Google Scholar
• Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study. Arthritis Res Ther. 2011;13(2):R66. doi:10.1186/ar332221501486
   PubMed Web of Science ®Google Scholar
• Li YH, Lin GM. Sex differences in the association between serum uric acid and cardiac mortality in Asian patients with established coronary artery disease: a revisit of the ET-CHD registry in Taiwan, 1997–2003. J Cardiol. 2016;68(5):461. doi:10.1016/j.jjcc.2016.02.008
   Web of Science ®Google Scholar
• Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520–2526. doi:10.1002/jbmr.226924771492
   PubMed Web of Science ®Google Scholar
• Odén A, McCloskey EV, Kanis JA, Harvey NC, Johansson H. Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int. 2015;26(9):2243–2248. doi:10.1007/s00198-015-3154-626018089
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, Everitt A, Lebel M. The aging liver. Geriatr Aging. 2009;12:319–322.
   Google Scholar